Erectile Dysfunction Market Industry Analysis and Opportunities Assessment to 2026

According to study conducted by Canadian Institute of Health Research, there were about 4,000 Canadian men between the age 40 and 88 years, nearly half of them had erectile dysfunction. It was about approximately two times more usual in men with cardiovascular disease and four times more usual among men suffering with any kind of diabetes. Increase in the number of erectile dysfunction cases has led to an increase in the Cialis drugs, proportionally boost the erectile dysfunction market.

The global erectile dysfunction market was valued at US$ 4,129.5 million in 2015 and is expected to witness a CAGR of 0.2% during the forecast period (2016 – 2024).

According to pharma industry news, in 2012, Viagra drugs dominated the erectile dysfunction market with an approximate market share of about 45% in terms of revenue. Though, the market value for Viagra has declined due to its patent expiry in European countries by 2013, however the other pharmaceutical companies has then shown a keen interest in developing the generic Viagra drug for erectile dysfunction treatment. In-spite the patent loss, US market maintained a continual growth and is expected to dominate the erectile dysfunction market by 2020. The other prominent drug after Viagra is Cialis which holds the second largest market share globally. At present the market for Cialis drug is growing exceptionally well, however there can be an expected decline of Cialis’s drug market share as the patent expiration is due in mid of 2017.

Furthermore, one of the Bayer’s erectile dysfunction drug, Levitra/Staxyn is expected to lose its patent by 2018 and is thus expected to contribute to the declining market revenue for Erectile Dysfunction Market. However, as there about 50 drug molecules under clinical trials, among which few drugs are expected to launch by 2018 and 2019 owing to increase in Erectile Dysfunction Market proportionally.

Access PDF Template Copy of this Report at:
https://www.coherentmarketinsights.com/insight/request-sample/200

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global erectile dysfunction market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Key companies covered as a part of this study include Meda Pharmaceuticals, Inc., Coloplast, Global Life Technologies, Reflexonic, LLC, Augusta Medical System, Boston Scientific Corporation, and Vivus, Inc.

Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, end user upgrades, market expansion, and marketing tactics

The global erectile dysfunction market report caters to various stakeholders in this industry, including investors, drug manufacturers, distributors and suppliers for erectile dysfunction products, research and consulting firms, new entrants, and financial analysts
Various strategy matrices used in analyzing the erectile dysfunction market would provide stakeholders vital inputs to make strategic decisions accordingly

Get Customized Report in your Inbox within 24 hours @
https://www.coherentmarketinsights.com/insight/request-customization/200

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.